Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study.
Saved in:
| Title: | Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study. |
|---|---|
| Authors: | Cabasag CJ; International Agency for Research on Cancer, Lyon, France., Arnold M; International Agency for Research on Cancer, Lyon, France., Rutherford M; International Agency for Research on Cancer, Lyon, France.; Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, UK., Ferlay J; International Agency for Research on Cancer, Lyon, France., Bardot A; International Agency for Research on Cancer, Lyon, France., Morgan E; International Agency for Research on Cancer, Lyon, France.; Northern Ireland Cancer Registry, Center for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK., Butler J; Royal Marsden Hospital, London, England, UK., O'Connell DL; The Daffodil Center, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia., Nelson G; Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada., Høgdall C; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Schnack T; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Odense University Hospital, Odense, Denmark., Gavin A; Northern Ireland Cancer Registry, Center for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK., Elwood M; Department of Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand., Hanna L; Velindre Cancer Center, Cardiff, Wales, UK., Gourley C; Institute of Genetics and Cancer, Cancer Research UK Edinburgh Center, The University of Edinburgh, Edinburgh, Scotland, UK., De P; Ontario Health, Toronto, Canada., Saint-Jacques N; Nova Scotia Health Cancer Care Program, Halifax, Nova Scotia, Canada., Mørch LS; The Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Copenhagen, Denmark., Woods RR; Cancer Control Research, BC Cancer, Vancouver, British Columbia, Canada., Altman AD; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Manitoba, Manitoba, Canada.; CancerCare Manitoba Research Institute, Manitoba, Canada., Sykes P; University of Otago, Christchurch, New Zealand., Cohen PA; Department of Gynaecological Oncology, St John of God Subiaco Hospital, Perth, Western Australia, Australia.; Discipline of Obstetrics and Gynaecology, Medical School, University of Western Australia, Perth, Western Australia, Australia., McNally O; Royal Women's Hospital, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Møller B; Cancer Registry of Norway, Oslo, Norway., Walsh P; National Cancer Registry Ireland, Cork, Ireland., Morrison DS; Scottish Cancer Registry, Scotland, UK., Bray F; International Agency for Research on Cancer, Lyon, France., Soerjomataram I; International Agency for Research on Cancer, Lyon, France. |
| Source: | International journal of cancer [Int J Cancer] 2023 May 01; Vol. 152 (9), pp. 1763-1777. Date of Electronic Publication: 2023 Jan 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0215 |
|---|---|
| DOI: | 10.1002/ijc.34403 |
